Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
University of South Florida, Tampa, Florida Emory University- Winship Cancer Institute, Atlanta, Georgia Massachusetts General Hospital, Boston, Massachusetts Icahn School of Medicine at Mount Sinai, New York, New York The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania Spain
Clinica Universidad de Navarra - Madrid, Madrid Clinica Universidad de Navarra- Pamplona, Pamplona